Currency: USD
Period
Q4 FY2023 Earnings
--
305.01K
-22.86M
No Data
Revenue
EPS
EBIT
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 10-K: Annual report
Mar 29 13:23 ET
SAB BIOTHERAPEUTICS INC C/WTS 22/10/2026 (TO PUR COM) | 10-Q: Quarterly report
Nov 13, 2023 16:48 ET
Aug 21, 2023 08:23 ET
May 15, 2023 16:50 ET
Read more